212,213 The pathophysiological mechanism of GLP-1 in metabolic diseases GLP-1 plays a crucial role in the pathophysiology of metabolic diseases, particularly in T2DM and obesity
Dispose of unneeded medications safely to prevent accidental ingestion
Most patients experience weight regain after discontinuing GLP-1 therapy, as obesity is a chronic condition requiring ongoing management
Ongoing Support Regular follow-ups keep you motivated, safe, and progressing toward your goals, which is a cornerstone of our holistic weight management model
Follow-up appointments occur monthly or as recommended by your provider to track weight loss, adjust doses, and ensure the medication remains safe and effective for your situation
Direct cardiovascular effects of glucagon like peptide-1